FMP
Fidelity Select Portfolios - Medical Technology and Devices Portfolio
FSMEX
NASDAQ
The fund normally invests at least 80% of its assets in securities of companies principally engaged in research, development, manufacture, distribution, supply, or sale of medical equipment, devices, and related technologies, companies enabling drug discovery, and companies providing information technology services primarily to health care providers. It invests primarily in common stocks. The fund invests in domestic and foreign issuers. The fund is non-diversified.
63.27 USD
0.4 (0.632%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
None
sector
N/A
industry
N/A
website
N/A
exchange
NASDAQ
Description
The fund normally invests at least 80% of its assets in securities of companies principally engaged in research, development, manufacture, distribution, supply, or sale of medical equipment, devices, and related technologies, companies enabling drug discovery, and companies providing information technology services primarily to health care providers. It invests primarily in common stocks. The fund invests in domestic and foreign issuers. The fund is non-diversified.
CIK
0000320351
ISIN
US3163904754
CUSIP
N/A
Address
Fidelity Select Portfolios
Phone
800-544-8544
Country
US
Employee
N/A
IPO Date
Apr 28, 1998
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
FSMEX Financial Summary
CIK
0000320351
Exchange
NASDAQ
Industry
-
Sector
-
CUSIP
-
ISIN
US3163904754
Country
US
Price
63.27
Beta
1.08
Volume Avg.
0
Market Cap
5.32B
Shares
-
52-Week
60.09-69.41
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-
P/B
-
Website
-
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest FSMEX News
It looks like there's no news available.
